Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

By | November 1, 2021
The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.